Serum tumor markers and testicular germ cell tumors: a primer for radiologists.
Biomarkers
Radiologists
Radiology
Seminoma/diagnosis
Testicular germ cell tumor
Testicular neoplasms
Tumor
Journal
Abdominal radiology (New York)
ISSN: 2366-0058
Titre abrégé: Abdom Radiol (NY)
Pays: United States
ID NLM: 101674571
Informations de publication
Date de publication:
03 2019
03 2019
Historique:
pubmed:
13
12
2018
medline:
21
4
2020
entrez:
13
12
2018
Statut:
ppublish
Résumé
Serum tumor markers (STMs) play a critical role in the diagnosis, staging and follow-up of both seminomatous and nonseminomatous testicular germ cell neoplasms. Levels of alpha-fetoprotein (AFP), human chorionic gonadotropin (HCG), and lactate dehydrogenase (LDH), especially those measured after orchiectomy, also have implications for patient prognosis. Given that testicular germ cell tumors represent the most common solid tumor in men aged 20-34, radiologists must have familiarity with the clinical utilization and implications of these STMs. This article will review the classical patterns of STM elevation most commonly seen in pure seminomatous and nonseminomatous germ cell tumors while also providing case-based examples highlighting the importance of STM correlation with imaging. The role of STMs in clinical staging and disease surveillance will also be discussed.
Identifiants
pubmed: 30539249
doi: 10.1007/s00261-018-1846-z
pii: 10.1007/s00261-018-1846-z
doi:
Substances chimiques
Biomarkers, Tumor
0
Chorionic Gonadotropin
0
Contrast Media
0
alpha-Fetoproteins
0
L-Lactate Dehydrogenase
EC 1.1.1.27
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM